Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Fluticasone/Salmeterol vs Advair Diskus in Asthma
NCT03535870Completed
- Sponsor
- Roxane Laboratories
- Start
- Apr 2018
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial in asthma comparing Generic Fluticasone/Salmeterol, Advair Diskus and Placebo (3 arms). Primary endpoints: FEV1-time curve (day 1) and FEV1-time curve (day 28). Started Apr 2018; status: completed.
02
Drugs
fluticasone propionate nasal spraysalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03535870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03535870.